Bradmer plans to list on Toronto Stock Exchange

By Elaine Rigoli

Tampa, Fla., March 31 - Bradmer Pharmaceuticals, Inc. announced Friday that its common shares have been conditionally approved for listing on the Toronto Stock Exchange.

Bradmer is currently listed on the TSX Venture Exchange.

Listing is subject to Bradmer fulfilling all of the requirements of the Toronto Stock Exchange on or before June 27.

Upon listing, Bradmer's common shares will continue to trade under the symbol "BMR."

Bradmer is a biotechnology company based in Toronto, Ont., that develops and commercializes cancer therapies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.